Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11045)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 28, 2016 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chan AK, Bruce JI, Siriwardena AK. Glucose metabolic phenotype of pancreatic cancer. World J Gastroenterol 2016; 22(12): 3471-3485 [PMID: 27022229 DOI: 10.3748/wjg.v22.i12.3471] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i12/3471.htm |
| Number | Citing Articles |
| 1 |
Artur Wnorowski, Danuta Dudzik, Michel Bernier, Jakub Wójcik, Guido Keijzers, Alberto Diaz-Ruiz, Karolina Mazur, Yongqing Zhang, Haiyong Han, Morten Scheibye-Knudsen, Krzysztof Jozwiak, Coral Barbas, Irving W. Wainer. Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-07600-x
|
| 2 |
Sonam Kumari, Sheema Khan, Subash C. Gupta, Vivek K. Kashyap, Murali M. Yallapu, Subhash C. Chauhan, Meena Jaggi. MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer. Oncogenesis 2018; 7(2) doi: 10.1038/s41389-018-0031-0
|
| 3 |
Natalia E. Cortez, Gerardo G. Mackenzie. Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives. Nutrients 2021; 13(9): 3202 doi: 10.3390/nu13093202
|
| 4 |
Laura Di Magno, Antonio Coluccia, Marianna Bufano, Silvia Ripa, Giuseppe La Regina, Marianna Nalli, Fiorella Di Pastena, Gianluca Canettieri, Romano Silvestri, Luigi Frati. Discovery of novel human lactate dehydrogenase inhibitors: Structure-based virtual screening studies and biological assessment. European Journal of Medicinal Chemistry 2022; 240: 114605 doi: 10.1016/j.ejmech.2022.114605
|
| 5 |
Shonagh Russell, Robert A. Gatenby, Robert J. Gillies, Arig Ibrahim-Hashim. Ecology and Evolution of Cancer. 2017; : 57 doi: 10.1016/B978-0-12-804310-3.00004-1
|
| 6 |
Juan M. González-Morena, Francisco J. Sánchez-Gómez, Yolanda Vida, Ezequiel Pérez-Inestrosa, María Salas, María I. Montañez, Alessandra Altomare, Giancarlo Aldini, María A. Pajares, Dolores Pérez-Sala. Amoxicillin Haptenation of α-Enolase is Modulated by Active Site Occupancy and Acetylation. Frontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.807742
|
| 7 |
Yi-Fang Yang, Hao-Wen Chuang, Wei-Ting Kuo, Bo-Syuan Lin, Yu-Chan Chang. Current Development and Application of Anaerobic Glycolytic Enzymes in Urothelial Cancer. International Journal of Molecular Sciences 2021; 22(19): 10612 doi: 10.3390/ijms221910612
|
| 8 |
A. V. Snezhkina, G. S. Krasnov, S. O. Zhikrivetskaya, I. Y. Karpova, M. S. Fedorova, K. M. Nyushko, M. M. Belyakov, N. V. Gnuchev, D. V. Sidorov, B. Y. Alekseev, N. V. Melnikova, A. V. Kudryavtseva. Overexpression of microRNAs miR-9, -98, and -199 Correlates with the Downregulation of HK2 Expression in Colorectal Cancer. Molecular Biology 2018; 52(2): 190 doi: 10.1134/S0026893318020140
|
| 9 |
Diana Tavares-Valente, Stefania Cannone, Maria Raffaella Greco, Tiago Miguel Amaral Carvalho, Fátima Baltazar, Odília Queirós, Gennaro Agrimi, Stephan J. Reshkin, Rosa Angela Cardone. Extracellular Matrix Collagen I Differentially Regulates the Metabolic Plasticity of Pancreatic Ductal Adenocarcinoma Parenchymal Cell and Cancer Stem Cell. Cancers 2023; 15(15): 3868 doi: 10.3390/cancers15153868
|
| 10 |
Cong Tan, Xin Wang, Xu Wang, Weiwei Weng, Shu-juan Ni, Meng Zhang, Hesheng Jiang, Lei Wang, Dan Huang, Weiqi Sheng, Mi-die Xu. Molecular signatures of tumor progression in pancreatic adenocarcinoma identified by energy metabolism characteristics. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09487-3
|
| 11 |
Hwaida M. Mokhtar, Amira Youssef, Tamer M. Naguib, Amr A. Magdy, Samir A. Salama, Ahmed M. Kabel, Nesreen M. Sabry. The Significance of FDG PET/CT–Derived Parameters in Determining Prognosis of Cases with Pancreatic Adenocarcinoma: A Prospective Study. Medicina 2022; 58(8): 1027 doi: 10.3390/medicina58081027
|
| 12 |
Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Tomas Koltai, Khalid O. Alfarouk, Stephan J. Reshkin, Rosa A. Cardone. Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches. Cancers 2021; 13(23): 6135 doi: 10.3390/cancers13236135
|
| 13 |
Tzu-Chin Wu, Chien-Yu Liao, Wei-Chien Lu, Chuang-Rung Chang, Fang-Yu Tsai, Shih-Sheng Jiang, Tsung-Hsien Chen, Kurt Ming-Chao Lin, Li-Tzong Chen, Wun-Shaing Wayne Chang. Identification of distinct slow mode of reversible adaptation of pancreatic ductal adenocarcinoma to the prolonged acidic pH microenvironment. Journal of Experimental & Clinical Cancer Research 2022; 41(1) doi: 10.1186/s13046-022-02329-x
|
| 14 |
Dingyuan Hu, Daniel Ansari, Krzysztof Pawłowski, Qimin Zhou, Agata Sasor, Charlotte Welinder, Theresa Kristl, Monika Bauden, Melinda Rezeli, Yi Jiang, György Marko-Varga, Roland Andersson. Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma. Oncotarget 2018; 9(11): 9789 doi: 10.18632/oncotarget.23929
|
| 15 |
Elvira Pelosi, Germana Castelli, Ugo Testa. Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. Biomedicines 2017; 5(4): 65 doi: 10.3390/biomedicines5040065
|
| 16 |
Nour Obeidat, Malek Zihlif, Dana Alqudah, Walhan Alshaer, Moath Alqaraleh, Shtaywy Abdalla. Effects of cyclic acute and chronic hypoxia on the expression levels of metabolism related genes in a pancreatic cancer cell line. Biomedical Reports 2022; 17(4) doi: 10.3892/br.2022.1564
|
| 17 |
Shu‑Jing Wang, Jian‑Kai Zhao, Shuang Ren, Wei‑Wei Sun, Wen‑Jun Zhang, Jia‑Ning Zhang. Wogonin affects proliferation and the energy metabolism of SGC‑7901 and A549 cells. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.7023
|
| 18 |
Jing-Ru Weng, Balraj Gopula, Po-Chen Chu, Jing-Lan Hu, Chia-Hsien Feng. A PKM2 inhibitor induces apoptosis and autophagy through JAK2 in human oral squamous cell carcinoma cells. Chemico-Biological Interactions 2023; 380: 110538 doi: 10.1016/j.cbi.2023.110538
|
| 19 |
Cristoforo Grasso, Gerrit Jansen, Elisa Giovannetti. Drug resistance in pancreatic cancer: Impact of altered energy metabolism. Critical Reviews in Oncology/Hematology 2017; 114: 139 doi: 10.1016/j.critrevonc.2017.03.026
|
| 20 |
Wei Mu, Zhe Wang, Margot Zöller. Ping-Pong—Tumor and Host in Pancreatic Cancer Progression. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01359
|
| 21 |
Xiu‐Ping Zhang, Qinjunjie Chen, Qu Liu, Yang Wang, Fei Wang, Zhi‐Ming Zhao, Guo‐Dong Zhao, Wan Yee Lau, Yu‐Zhen Gao, Rong Liu. Development and validation of glycolysis‐related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma. Journal of Cellular and Molecular Medicine 2021; 25(12): 5615 doi: 10.1111/jcmm.16573
|
| 22 |
Yuehui Liang, Qi Liang, Liang Qiao, Fang Xiao. MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular Carcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00920
|
| 23 |
Paola Cappello, Claudia Curcio, Giorgia Mandili, Cecilia Roux, Sara Bulfamante, Francesco Novelli. Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners. Cancers 2018; 10(2): 51 doi: 10.3390/cancers10020051
|
| 24 |
Makoto Takahashi, Hiroyuki Nojima, Satoshi Kuboki, Takuro Horikoshi, Tetsuo Yokota, Hideyuki Yoshitomi, Katsunori Furukawa, Tsukasa Takayashiki, Shigetsugu Takano, Masayuki Ohtsuka. Comparing prognostic factors of Glut-1 expression and maximum standardized uptake value by FDG-PET in patients with resectable pancreatic cancer. Pancreatology 2020; 20(6): 1205 doi: 10.1016/j.pan.2020.07.407
|
| 25 |
Giulia Nannini, Gaia Meoni, Amedeo Amedei, Leonardo Tenori. Metabolomics profile in gastrointestinal cancers: Update and future perspectives. World Journal of Gastroenterology 2020; 26(20): 2514-2532 doi: 10.3748/wjg.v26.i20.2514
|
| 26 |
Xialin Luo, Jingjing Liu, Huaizhi Wang, Haitao Lu. Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis. Pharmacological Research 2020; 156: 104805 doi: 10.1016/j.phrs.2020.104805
|
| 27 |
Yi Zhang, Qiong Li, Zhao Huang, Bowen Li, Edouard C. Nice, Canhua Huang, Liuya Wei, Bingwen Zou. Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies. Cancers 2022; 14(19): 4568 doi: 10.3390/cancers14194568
|
| 28 |
Laura Follia, Giulio Ferrero, Giorgia Mandili, Marco Beccuti, Daniele Giordano, Rosella Spadi, Maria Antonietta Satolli, Andrea Evangelista, Hiroyuki Katayama, Wang Hong, Amin A. Momin, Michela Capello, Samir M. Hanash, Francesco Novelli, Francesca Cordero. Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00115
|